BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu J, Wu Q, Hao Y, Jiao M, Wang X, Jiang S, Han L. Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017. Hum Reprod 2021;36:1108-19. [PMID: 33501984 DOI: 10.1093/humrep/deaa371] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Bhandary P, Shetty PK, Manjeera L, Patil P. Hormonal, genetic, epigenetic and environmental aspects of polycystic ovarian syndrome. Gene Reports 2022;29:101698. [DOI: 10.1016/j.genrep.2022.101698] [Reference Citation Analysis]
2 Szukiewicz D, Trojanowski S, Kociszewska A, Szewczyk G. Modulation of the Inflammatory Response in Polycystic Ovary Syndrome (PCOS)—Searching for Epigenetic Factors. IJMS 2022;23:14663. [DOI: 10.3390/ijms232314663] [Reference Citation Analysis]
3 Park B, Lee H, Park S, Lee ES, Lee JJ, Lee Y, Seo JH. Trend changes and factor analysis of endometrial hyperplasia in patients with polycystic ovarian syndrome based on the Korean National Health Insurance Database. BMC Women's Health 2022;22:439. [DOI: 10.1186/s12905-022-02015-2] [Reference Citation Analysis]
4 Chiaffarino F, Cipriani S, Dalmartello M, Ricci E, Esposito G, Fedele F, La Vecchia C, Negri E, Parazzini F. Prevalence of Polycystic Ovary Syndrome in European countries and USA: a systematic review and meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology 2022. [DOI: 10.1016/j.ejogrb.2022.10.020] [Reference Citation Analysis]
5 Olaniyi KS, Areloegbe SE, Oyeleke MB. Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity. Endocrine. [DOI: 10.1007/s12020-022-03191-9] [Reference Citation Analysis]
6 Tay CT, Joham AE, Moran LJ, Teede H. Better care for women with polycystic ovary syndrome - a proposal for an international evidence based best practice framework to improve care. Curr Opin Endocrinol Diabetes Obes 2022. [PMID: 36081355 DOI: 10.1097/MED.0000000000000770] [Reference Citation Analysis]
7 Haghollahi F, Heidary Z, Bagheri M, Masoumi M, Ghaemi M. Polycystic Ovary Syndrome in Adolescence: From the Cradle to the Grave. Fertility Gynecology Andrology 2022;2. [DOI: 10.5812/fga-129248] [Reference Citation Analysis]
8 Kim JH, Jung MH, Hong SH, Moon N, Kang DR. Age-Adjusted Prevalence and Characteristics of Women with Polycystic Ovarian Syndrome in Korea: A Nationwide Population-Based Study (2010-2019). Yonsei Med J 2022;63:794-8. [PMID: 35914763 DOI: 10.3349/ymj.2022.63.8.794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Muccee F, Bijou O, Harakeh S, Adawiyah R, Sayyed RZ, Haghshenas L, Alshehri D, Ansari MJ, Ghazanfar S. In-Silico Investigation of Effects of Single-Nucleotide Polymorphisms in PCOS-Associated CYP11A1 Gene on Mutated Proteins. Genes 2022;13:1231. [DOI: 10.3390/genes13071231] [Reference Citation Analysis]
10 Juliawan IMP, Suwana FP, Annas JY, Akbar MF, Widjiati W. High Sucrose and Cholic Acid Diet Triggers PCOS-like Phenotype and Reduces Enterobacteriaceae Colonies in Female Wistar Rats. Pathophysiology 2022;29:344-53. [PMID: 35893596 DOI: 10.3390/pathophysiology29030026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zeng R, Chen H, Zeng X, Qin L. The Essential Role of Body Weight in Adjusting Gn Dosage to Prevent High Ovarian Response for Women With PCOS During IVF: A Retrospective Study. Front Endocrinol 2022;13:922044. [DOI: 10.3389/fendo.2022.922044] [Reference Citation Analysis]
12 Yang R, Li Q, Zhou Z, Qian W, Zhang J, Wu Z, Jin L, Wu X, Zhang C, Zheng B, Tan J, Hao G, Li S, Tian T, Hao Y, Zheng D, Wang Y, Norman RJ, Li R, Liu P, Qiao J. Changes in the prevalence of polycystic ovary syndrome in China over the past decade. Lancet Reg Health West Pac 2022;25:100494. [PMID: 35669932 DOI: 10.1016/j.lanwpc.2022.100494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Rashid R, Shah IA, Asrar MM, Godha M, Ganai BA, Ganie MA. Family history of menstrual irregularity or diabetes mellitus enhances the susceptibility to polycystic ovary syndrome among subjects harboring rs7903146 genetic variant of TCF7L2. J Diabetes Metab Disord 2022;21:769-76. [PMID: 35673429 DOI: 10.1007/s40200-022-01050-y] [Reference Citation Analysis]
14 Khil J, Darbinian JA, Guo L, Greenspan LC, Ramalingam ND, Lo JC. Ethnic diversity and burden of polycystic ovary syndrome among US adolescent females. J Pediatr Endocrinol Metab 2022. [PMID: 35596599 DOI: 10.1515/jpem-2022-0160] [Reference Citation Analysis]
15 Li X, Zhu L, Luo Y. Long non-coding RNA HLA-F antisense RNA 1 inhibits the maturation of microRNA-613 in polycystic ovary syndrome to promote ovarian granulosa cell proliferation and inhibit cell apoptosis. Bioengineered 2022;13:12289-97. [DOI: 10.1080/21655979.2022.2070965] [Reference Citation Analysis]
16 Motlagh Asghari K, Nejadghaderi SA, Alizadeh M, Sanaie S, Sullman MJM, Kolahi AA, Avery J, Safiri S. Burden of polycystic ovary syndrome in the Middle East and North Africa region, 1990-2019. Sci Rep 2022;12:7039. [PMID: 35488014 DOI: 10.1038/s41598-022-11006-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 L.j. Visseren F, Mach F, M. Smulders Y, Carballo D, C. Koskinas K, Bäck M, Benetos A, Biffi A, Manuel Boavida J, Capodanno D, Cosyns B, Crawford C, H. Davos C, Desormais I, Di Angelantonio E, H. Franco O, Halvorsen S, Richard Hobbs F, Hollander M, A. Jankowska E, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, P. Tsioufis K, van Dis I, C. van Gelder I, Wanner C, Williams B. Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2021.10.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li P, Peng J, Ding Z, Zhou X, Liang R. Effects of Acupuncture Combined with Moxibustion on Reproductive and Metabolic Outcomes in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-15. [DOI: 10.1155/2022/3616036] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Min D, Jang IS, Park S. Preventive Behavior Intentions for Polycystic Ovary Syndrome in Young Students. Metab Syndr Relat Disord 2022. [PMID: 35262419 DOI: 10.1089/met.2021.0123] [Reference Citation Analysis]
20 Farhadi-azar M, Behboudi-gandevani S, Rahmati M, Mahboobifard F, Khalili Pouya E, Ramezani Tehrani F, Azizi F. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study. Front Endocrinol 2022;13:825528. [DOI: 10.3389/fendo.2022.825528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Basak R, Banerjee A, Rai U. Demystifying Bisphenol A-Induced Alterations in Hypothalamic-Pituitary-Ovarian Functions Leading to Polycystic Ovarian Syndrome. Proc Zool Soc 2021;74:466-78. [DOI: 10.1007/s12595-021-00407-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC Scientific Document Group . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol 2021:zwab154. [PMID: 34558602 DOI: 10.1093/eurjpc/zwab154] [Cited by in Crossref: 40] [Cited by in F6Publishing: 54] [Article Influence: 40.0] [Reference Citation Analysis]
23 Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC National Cardiac Societies., ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42:3227-337. [PMID: 34458905 DOI: 10.1093/eurheartj/ehab484] [Cited by in Crossref: 625] [Cited by in F6Publishing: 714] [Article Influence: 625.0] [Reference Citation Analysis]
24 Hammarstrand S, Jakobsson K, Andersson E, Xu Y, Li Y, Olovsson M, Andersson EM. Perfluoroalkyl substances (PFAS) in drinking water and risk for polycystic ovarian syndrome, uterine leiomyoma, and endometriosis: A Swedish cohort study. Environ Int 2021;157:106819. [PMID: 34391986 DOI: 10.1016/j.envint.2021.106819] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]